BioCina Overview

  • Year Founded
  • 1982

Year Founded

  • Status
  • Private

  • Employees
  • 68

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 6

  • Investments
  • 2

BioCina General Information

Description

Operator of a biologics contract development and manufacturing organization (CDMO) intended to focus on developing microbial-based biological pharmaceuticals. The company specializes in designing and manufacturing products including proteins, plasmid DNA, mRNA, vaccines and biosimilars from early development through to commercialization as well as offers quality and regulatory testing services, enabling its clients to address technical issues and their needs affordably.

Contact Information

Website
www.biocina.com
Formerly Known As
BresaGen
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 8 Dalgleish Street
  • Thebarton
  • Adelaide, South Australia 5031
  • Australia
+61 (08)
Primary Industry
BPO/Outsource Services
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Corporate Office
  • 8 Dalgleish Street
  • Thebarton
  • Adelaide, South Australia 5031
  • Australia
+61 (08)

BioCina Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioCina Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioCina‘s full profile, request access.

Request a free trial

BioCina Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioCina Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioCina‘s full profile, request access.

Request a free trial

BioCina Investments (2)

BioCina’s most recent deal was a Buyout/LBO with NovaCina. The deal was made on 27-Feb-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NovaCina 27-Feb-2024 Buyout/LBO Other Pharmaceuticals and Biotechnology
Pfizer (Manufacturing Plant at Thebarton) 05-Oct-2021 Buyout/LBO BPO/Outsource Services
To view BioCina’s complete investments history, request access »

BioCina FAQs

  • When was BioCina founded?

    BioCina was founded in 1982.

  • Where is BioCina headquartered?

    BioCina is headquartered in Adelaide, Australia.

  • What is the size of BioCina?

    BioCina has 68 total employees.

  • What industry is BioCina in?

    BioCina’s primary industry is BPO/Outsource Services.

  • Is BioCina a private or public company?

    BioCina is a Private company.

  • What is BioCina’s current revenue?

    The current revenue for BioCina is .

  • How much funding has BioCina raised over time?

    BioCina has raised $3.54M.

  • Who are BioCina’s investors?

    Invest & Trade Western Australia, National Health and Medical Research Council, Australian Government (Landing Pads), and Bridgewest Group have invested in BioCina.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process